Autoimmune encephalitis after BBIBP-CorV (Sinopharm) COVID-19 vaccination: a case report

Keyphrases

• Vaccination 100%
• Autoimmune Encephalitis 100%
• Encephalitis 100%
• BBIBP-CorV 100%
• COVID-19 Vaccination 100%
• Sinopharm 100%
• Second Dose 100%
• Clinical Relapse 100%
• Insomnia 50%
• Latin America (LATAM) 50%
• Headache 50%
• Fever 50%
• Lack of Response 50%
• Older Women 50%
• Immunosuppressive Therapy 50%
• Brain Magnetic Resonance Imaging 50%
• Clinical Evolution 50%
• Caudate nucleus 50%
• Methylprednisolone 50%
• Vaccine against COVID-19 50%
• Oncologic 50%
• BBIBP-CorV Vaccine 50%
• Immunoglobulin 50%
• Demyelinating Lesions 50%
• First Dose 50%
• Infratentorial 50%
• Rare Manifestation 50%
• Public Health Strategies 50%
• Neural Autoantibodies 50%
• Imaging Pattern 50%
• Neurological Effects 50%
• Supratentorial 50%
• Corticosteroid Therapy 50%
• Disconnection 50%
• New Cycle 50%

Medicine and Dentistry

• Encephalitis 100%
• COVID-19 Vaccination 100%
• Allergic Encephalitis 100%
• Magnetic Resonance Imaging 50%
• Adverse Event 50%
• Public Health 50%
• Headache 50%
• Immunosuppressive Treatment 50%
• Case Presentation 50%
• Corticosteroid Therapy 50%
• COVID-19 50%
• Methylprednisolone 50%
• Immunoglobulin 50%
• Autoantibodies 50%
• Caudate Nucleus 50%